Advertisement
News
Advertisement

AMRI Extends Long Term Supply Relationship with GE Healthcare

Thu, 12/06/2012 - 4:41am

AMRI today announced the extension of a commercial supply relationship with GE Healthcare for Aminobisamide Hydrochloride (ABA). Under the terms of the agreement, AMRI will supply ABA, an intermediate material used in diagnostic imaging agents. This substantial contract commitment positions AMRI as a strategic supplier to GE Healthcare.

Production will continue at AMRI’s large scale manufacturing subsidiary located in Rensselaer, N.Y. The new contract extends through December 31, 2016, and replaces the existing supply contract between GE and AMRI that has been in effect since 2005.

“We are pleased to once again extend our long-term relationship with GE Healthcare,” said AMRI Chairman, CEO and President Thomas E. D’Ambra, Ph.D. “The renewal of this relationship underscores the confidence that premier global pharmaceutical and health care companies have in AMRI’s ability to meet their critical product needs.

Dr. D’Ambra continued, “The ABA product relationship with GE Healthcare has been an important one for AMRI since acquisition of the Rensselaer plant in 2003 and at this time is our largest commercial supply arrangement. We continue to be pleased with the progress that we are making in our Large Scale Manufacturing business segment, the largest component of which is our Rensselaer site. We are adding new customers and new products at this facility, along with continuing the long-term relationships, like GE Healthcare, that have formed the basis of our revenue stream. The extension of this key, long term agreement provides a consistent and high quality revenue source for this business unit through 2016.”

 

 

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading